Also, please send comments or questions to us via the chat function

It seems that she is moving forward, but slides are not

Agreed

Thanks to you both for letting us know..

Can/how often are Stage 1 & Stage 2 research combined?

The Onken et al Stage Model is very parallel to the translational research model used in CTSA's, in cancer research (for many years - Greenwald et al.), and so on. Do you (or does Lisa et al.) see it as the behavioral science/change adaptation of those models?

Thanks for joining us Dr. Onken

So this target is then a mediator on the causal pathway?

Can you explain how you differentiate "theory" vs "model"? What makes something a theory vs model - since the terms are often used interchangeably?

Do we know what is causing that sound?

Nevermind.

When we are considering these different frameworks, on what factors should we base the selection of one framework over another?

Do intervention development models address the idea that people respond differently to interventions (i.e. heterogenous treatment effects)? If not, do you have any suggestions for how to take that into consideration when we develop and test interventions?

Interesting question, Megan. I would think heterogeneity of treatment effects is better defined in the analytic model (vs. intervention development models). Thinking sub-group analyses to test impactful mediating factors etc., but this predicated on a large and diverse patient sample by which to appropriately look at this heterogeneity across groups and clinical characteristics. Would be curious what you and others think.

That is my sense, Katherine, and what I messaged to MSB. Speaks to cultural adaptation and tailoring

That makes sense and I agree with the need for large and diverse samples and then plan to do sub-group analyses. I wonder whether some preliminary work during early stages can start to get at this because sometimes we don't know/can't anticipate which characteristics will affect treatment. This has been a great presentation--thank you!

Agreed!!

This has been a great talk! Thanks for the opportunity to grow and learn.

Will the ppt file be shared to the attendees?

Slides and recording will be shared with everyone. Thanks for asking

Great. Thank you.

Thank you so much! this was fantastic

Thank you! This was outstanding.

Are there any broad differences in behavior change when the behavior hasn't begun yet (i.e. preventing behaviors from developing)? In pediatrics, we are often working on avoiding developing detrimental feeding behaviors. Are there specific models that address prevention?

Thank you for the presentation.

Thank you Dr. Czajkowksi!

This was fantastic, thank you thank you!